ANGELICA MARCUS: Open Payments
NPI 1265298178 · PLANTATION, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,642 in 68 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $481 · 2025 $1,642
Food & beverage: $1,642
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $290 |
| BioCryst US Sales Co., LLC | 12 | $220 |
| GlaxoSmithKline, LLC. | 12 | $192 |
| Novartis Pharmaceuticals Corporation | 6 | $140 |
| CSL Behring | 6 | $140 |
| Genentech, Inc. | 1 | $139 |
| Regeneron Healthcare Solutions, Inc. | 5 | $127 |
| GENZYME CORPORATION | 4 | $103 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $80 |
| OptiNose US, Inc. | 3 | $79 |
Products named: DUPIXENT, ORLADEYO, AIRSUPRA, Xolair, TRELEGY ELLIPTA, FASENRA, Andembry, NEFFY.
Industry payments across FL — which companies pay providers there.
